Gaza's Rafah border crossing, a main entry and exit point for the territory, has reopened after eight months to allow sick and wounded Palestinians to cross over into Egypt to receive medical ...

The 26-year-old, whose real name is Litzy Lara Banuelos, entered the rehab center for her addiction to the dissociative anesthetic drug, which she was taking 5 to 6 grams of per day, her family ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

A hyperbaric chamber exploded at the Oxford Center in Troy, Michigan, killing a 5-year-old boy being treated and injuring his ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...